Clinical Trials in Nashville

Showing 14761-14780 of 20,298 trials

Safety Study to Evaluate FluMist in Immunocompromised Children

NCT00112112

The main purpose of this study is to get information about the safety of a flu vaccine spray, called FluMist, in children with cancer. The study is also being done to find out how much and how long the vaccine spray can be found in the nose.

Cancer

MedImmune LLC20 participantsStarted Aug 2005

Rochester, New York, United States • Stony Brook, New York, United States • Memphis, Tennessee, United States +2 more locations

COMPLETEDPhase 1< 1 mile

A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors

NCT02223247

This first in human phase 1 study of TVB-2640 is being conducted in patients with advanced stage solid malignant tumors. This research is being done to find out how safe and useful TVB-2640 is for patients who have received previous cancer therapy, and for whom no therapy exists that would be curative or might provide significant benefit. TVB-2640 belongs to a class of drugs called fatty acid synthase inhibitors (FASN inhibitors). This means that they interfere with the body's (and the tumor's) ability to use a substance called fatty acid synthase (FASN). Research has shown that some tumors appear to need FASN to keep growing.

Solid Malignant Tumor

Sagimet Biosciences Inc.180 participantsStarted Nov 2013

Scottsdale, Arizona, United States • Denver, Colorado, United States • Sarasota, Florida, United States +8 more locations

Safety Study to Evaluate FluMist in Immunocompromised Children

A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors

Find Trials by Condition in Nashville

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment

Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment

A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)

Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System

HeRO Vascular Access Device Bacteremia Study

Biomarkers of Mild and Moderate Traumatic Brain Injury

Norwalk Vaccine Study

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients

A Safety Study of CNTO 2476 in Patients With Age-Related Macular Degeneration

Effect of VPro5 Therapy on Clear Aligner Therapy

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)